HOME > ARCHIVE

ARCHIVE

Tokyo Gov't Preparing for Switch to New Drug Manufacturing/Marketing System

February 14, 2005
Opinions Invited on Changes in Fees for Regulatory Procedures

February 14, 2005
REGULATORY NEWS IN BRIEF

February 14, 2005
MEETING

February 14, 2005
Failure to Act Damaging Weak Sector: Mr Mitchum of EFPIA Japan

February 14, 2005
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

February 14, 2005
DIAGNOSTIC NEWS IN BRIEF

February 14, 2005
RESEARCH & DEVELOPMENT NEWS IN BRIEF

February 14, 2005
Preparations for Merger Going Smoothly: Mr Miyatake of Dainippon

February 14, 2005
PRESS SEMINAR

February 14, 2005
Sumitomo Sets Up Merger Subcommittees

February 14, 2005
BULLETIN

February 14, 2005
BUSINESS NEWS IN BRIEF

February 14, 2005
Astellas to Start Out with 16,500 Employees Worldwide

February 14, 2005
WEBSITE NEWS

February 14, 2005
1st 3Qtrs Business Results -1-

February 14, 2005
1st 3Qtrs Business Results -2-

February 14, 2005
Annual Business Results

February 14, 2005
Semiannual Business Results

February 14, 2005
BULLETIN

February 7, 2005

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Shift Underway in Pharma Workforce as Sales Roles Shrink, Manufacturing Rises

By Hayate Horiguchi

Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…

COLUMN

The Patient North Star: How Gilead Japan Redefined Innovation

By Philip Carrigan

In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…